{"id":"W4404997121","doi":"10.1007/s40273-024-01456-x","title":"Cost-Effectiveness of Capivasertib as a Second-Line Therapy for Advanced Breast Cancer","year":2024,"lang":"en","type":"article","venue":"PharmacoEconomics","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Fulvestrant; Medicine; Cost effectiveness; Anastrozole; Breast cancer; Quality of Life Research; Oncology; Health economics; Internal medicine; Cancer; Gynecology; Tamoxifen; Public health; Nursing; Risk analysis (engineering)","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002112102,0.0006211495,0.001663147,0.0008587303,0.000189001,0.001551753,0.0005227176,0.001194645,0.00515395],"category_scores_gemma":[0.008199236,0.0002550869,0.003970026,0.0009612083,0.0003088794,0.00106125,0.0004852395,0.00209293,0.0002486363],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004494512,"about_ca_system_score_gemma":0.002529553,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008975397,"about_ca_topic_score_gemma":0.009388283,"domain_scores_codex":[0.997988,0.001226798,0.000114765,0.0001430201,0.0003278773,0.0001995605],"domain_scores_gemma":[0.9969399,0.001870834,0.0005138586,0.00007541676,0.0001617372,0.000438288],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.308081,0.004828711,0.04414426,0.004995398,0.01863516,0.0007578853,0.0001138443,0.0857374,0.003198624,0.005399789,0.014593,0.5095149],"study_design_scores_gemma":[0.1036762,0.1143737,0.4573083,0.004265481,0.07308258,0.004783121,0.001036037,0.1851404,0.005732616,0.009068859,0.04115067,0.0003820146],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8622439,0.09900539,0.001792342,0.01066702,0.0008604316,0.0006121064,0.005815535,0.0001370359,0.01886622],"genre_scores_gemma":[0.9912607,0.005490382,0.0004916415,0.0008093083,0.0001751727,0.00009563645,0.0009766908,0.00001035849,0.00069014],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008975397,"threshold_uncertainty_score":0.03261018,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04592795873233327,"score_gpt":0.4144842457790218,"score_spread":0.3685562870466885,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}